Serum levels of TNF-α, IL-6 and IL-10 in haemodialysis and renal transplant patients and in healthy subjects
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692016000300003 |
Resumo: | Background: Inflammatory processes seem to play an important role in the development of atherosclerosis. Recurrent or chronic inflammatory processes are common in individuals with end-stage renal disease. There isno consensus approach to assess the degree of severity of inflammation in individuals with kidney disease. In recent years, there has been a growing interest in the role of various cytokines in chronic kidney disease (CKD). Cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin 6 (IL-6) are mediators of inflammation that may play an important role in CKD. Interleukin 10 (IL-10) is a regulatory cytokine that seems to play a role in limiting inflammatory processes. Aim: The aim of this study was to evaluate the serum levels of TNF- α, IL-6 and IL-10 in a population of haemodialysis and renal transplant patients and in healthy subjects. Methods: This was a cross-sectional study. In 152 participants inflammation was assessed by measuring TNF-α, IL-6 and IL-10. The study included 53 haemodialysis patients, 45 renal transplant patients and 54 healthy subjects. Results: Serum levels of TNF-α were significantly higher in haemodialysis and renal transplant patients than in healthy subjects (40.2±10.8 vs 5.2±1.7 pg/mL; p<0.05; and 16.1±5.9 vs 5.2±1.7 pg/mL; p<0.05, respectively). Serum levels of IL-6 were significantly higher in haemodialysis patients than in healthy subjects (40.2±41.4 vs 16.4±5.4 pg/mL; p<0.05), whereas no significant difference was found between renal transplant patients and healthy subjects (20.1±8.3 vs 16.4±5.4 pg/mL; p=NS). Serum levels of IL-10 were significantly higher in haemodialysis and renal transplant patients than in healthy subjects (23.8±4.5 vs 10.5±3.9 pg/mL; p<0.05; and 19.4±3.1 vs 10.5±3.9 pg/mL; p<0.05, respectively). Conclusion: This study showed higher levels of inflammatory markers (TNF-α, IL-6) and of the regulatory cytokine IL-10 in haemodialysis patients than in healthy controls and higher levels of TNF-α and IL-10 in renal transplant patients than in healthy controls. In haemodialysis patients, increased levels of inflammatory markers usually predict a poor outcome |
id |
RCAP_d604d0eccc9bd969c7a38ab13e696fc9 |
---|---|
oai_identifier_str |
oai:scielo:S0872-01692016000300003 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Serum levels of TNF-α, IL-6 and IL-10 in haemodialysis and renal transplant patients and in healthy subjectsTNF-αIL-6IL-10chronic renal failurehemodialysisrenal transplantBackground: Inflammatory processes seem to play an important role in the development of atherosclerosis. Recurrent or chronic inflammatory processes are common in individuals with end-stage renal disease. There isno consensus approach to assess the degree of severity of inflammation in individuals with kidney disease. In recent years, there has been a growing interest in the role of various cytokines in chronic kidney disease (CKD). Cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin 6 (IL-6) are mediators of inflammation that may play an important role in CKD. Interleukin 10 (IL-10) is a regulatory cytokine that seems to play a role in limiting inflammatory processes. Aim: The aim of this study was to evaluate the serum levels of TNF- α, IL-6 and IL-10 in a population of haemodialysis and renal transplant patients and in healthy subjects. Methods: This was a cross-sectional study. In 152 participants inflammation was assessed by measuring TNF-α, IL-6 and IL-10. The study included 53 haemodialysis patients, 45 renal transplant patients and 54 healthy subjects. Results: Serum levels of TNF-α were significantly higher in haemodialysis and renal transplant patients than in healthy subjects (40.2±10.8 vs 5.2±1.7 pg/mL; p<0.05; and 16.1±5.9 vs 5.2±1.7 pg/mL; p<0.05, respectively). Serum levels of IL-6 were significantly higher in haemodialysis patients than in healthy subjects (40.2±41.4 vs 16.4±5.4 pg/mL; p<0.05), whereas no significant difference was found between renal transplant patients and healthy subjects (20.1±8.3 vs 16.4±5.4 pg/mL; p=NS). Serum levels of IL-10 were significantly higher in haemodialysis and renal transplant patients than in healthy subjects (23.8±4.5 vs 10.5±3.9 pg/mL; p<0.05; and 19.4±3.1 vs 10.5±3.9 pg/mL; p<0.05, respectively). Conclusion: This study showed higher levels of inflammatory markers (TNF-α, IL-6) and of the regulatory cytokine IL-10 in haemodialysis patients than in healthy controls and higher levels of TNF-α and IL-10 in renal transplant patients than in healthy controls. In haemodialysis patients, increased levels of inflammatory markers usually predict a poor outcomeSociedade Portuguesa de Nefrologia2016-09-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articletext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692016000300003Portuguese Journal of Nephrology & Hypertension v.30 n.3 2016reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692016000300003Alwahaibi,Nasar YousufAlissaei,Halima KhalfanAlshihi,Sara AbdullahAlabri,NadiaAlbalushi,Samya SulaimanAlbalooshi,Mohammedinfo:eu-repo/semantics/openAccess2024-02-06T17:04:53Zoai:scielo:S0872-01692016000300003Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T02:18:57.012034Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Serum levels of TNF-α, IL-6 and IL-10 in haemodialysis and renal transplant patients and in healthy subjects |
title |
Serum levels of TNF-α, IL-6 and IL-10 in haemodialysis and renal transplant patients and in healthy subjects |
spellingShingle |
Serum levels of TNF-α, IL-6 and IL-10 in haemodialysis and renal transplant patients and in healthy subjects Alwahaibi,Nasar Yousuf TNF-α IL-6 IL-10 chronic renal failure hemodialysis renal transplant |
title_short |
Serum levels of TNF-α, IL-6 and IL-10 in haemodialysis and renal transplant patients and in healthy subjects |
title_full |
Serum levels of TNF-α, IL-6 and IL-10 in haemodialysis and renal transplant patients and in healthy subjects |
title_fullStr |
Serum levels of TNF-α, IL-6 and IL-10 in haemodialysis and renal transplant patients and in healthy subjects |
title_full_unstemmed |
Serum levels of TNF-α, IL-6 and IL-10 in haemodialysis and renal transplant patients and in healthy subjects |
title_sort |
Serum levels of TNF-α, IL-6 and IL-10 in haemodialysis and renal transplant patients and in healthy subjects |
author |
Alwahaibi,Nasar Yousuf |
author_facet |
Alwahaibi,Nasar Yousuf Alissaei,Halima Khalfan Alshihi,Sara Abdullah Alabri,Nadia Albalushi,Samya Sulaiman Albalooshi,Mohammed |
author_role |
author |
author2 |
Alissaei,Halima Khalfan Alshihi,Sara Abdullah Alabri,Nadia Albalushi,Samya Sulaiman Albalooshi,Mohammed |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Alwahaibi,Nasar Yousuf Alissaei,Halima Khalfan Alshihi,Sara Abdullah Alabri,Nadia Albalushi,Samya Sulaiman Albalooshi,Mohammed |
dc.subject.por.fl_str_mv |
TNF-α IL-6 IL-10 chronic renal failure hemodialysis renal transplant |
topic |
TNF-α IL-6 IL-10 chronic renal failure hemodialysis renal transplant |
description |
Background: Inflammatory processes seem to play an important role in the development of atherosclerosis. Recurrent or chronic inflammatory processes are common in individuals with end-stage renal disease. There isno consensus approach to assess the degree of severity of inflammation in individuals with kidney disease. In recent years, there has been a growing interest in the role of various cytokines in chronic kidney disease (CKD). Cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin 6 (IL-6) are mediators of inflammation that may play an important role in CKD. Interleukin 10 (IL-10) is a regulatory cytokine that seems to play a role in limiting inflammatory processes. Aim: The aim of this study was to evaluate the serum levels of TNF- α, IL-6 and IL-10 in a population of haemodialysis and renal transplant patients and in healthy subjects. Methods: This was a cross-sectional study. In 152 participants inflammation was assessed by measuring TNF-α, IL-6 and IL-10. The study included 53 haemodialysis patients, 45 renal transplant patients and 54 healthy subjects. Results: Serum levels of TNF-α were significantly higher in haemodialysis and renal transplant patients than in healthy subjects (40.2±10.8 vs 5.2±1.7 pg/mL; p<0.05; and 16.1±5.9 vs 5.2±1.7 pg/mL; p<0.05, respectively). Serum levels of IL-6 were significantly higher in haemodialysis patients than in healthy subjects (40.2±41.4 vs 16.4±5.4 pg/mL; p<0.05), whereas no significant difference was found between renal transplant patients and healthy subjects (20.1±8.3 vs 16.4±5.4 pg/mL; p=NS). Serum levels of IL-10 were significantly higher in haemodialysis and renal transplant patients than in healthy subjects (23.8±4.5 vs 10.5±3.9 pg/mL; p<0.05; and 19.4±3.1 vs 10.5±3.9 pg/mL; p<0.05, respectively). Conclusion: This study showed higher levels of inflammatory markers (TNF-α, IL-6) and of the regulatory cytokine IL-10 in haemodialysis patients than in healthy controls and higher levels of TNF-α and IL-10 in renal transplant patients than in healthy controls. In haemodialysis patients, increased levels of inflammatory markers usually predict a poor outcome |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-09-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692016000300003 |
url |
http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692016000300003 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692016000300003 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Portuguesa de Nefrologia |
publisher.none.fl_str_mv |
Sociedade Portuguesa de Nefrologia |
dc.source.none.fl_str_mv |
Portuguese Journal of Nephrology & Hypertension v.30 n.3 2016 reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799137279620415488 |